SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001062993-15-001187
Filing Date
2015-03-05
Accepted
2015-03-05 16:46:20
Documents
4
Period of Report
2015-02-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K form8k.htm 8-K 52352
2 EXHIBIT 3.1 exhibit3-1.htm EX-3.1 47737
3 EXHIBIT 10.1 exhibit10-1.htm EX-10.1 35005
4 EXHIBIT 10.2 exhibit10-2.htm EX-10.2 52677
  Complete submission text file 0001062993-15-001187.txt   189442
Mailing Address 21 SPARROW CIRCLE WHITE PLAINS NY 10605
Business Address 21 SPARROW CIRCLE WHITE PLAINS NY 10605 (480) 659-6404
Orgenesis Inc. (Filer) CIK: 0001460602 (see all company filings)

IRS No.: 980583166 | State of Incorp.: NV | Fiscal Year End: 1130
Type: 8-K | Act: 34 | File No.: 000-54329 | Film No.: 15677884
SIC: 2834 Pharmaceutical Preparations